Part 1 and 2: PharmaDrug CEO Daniel Cohen On Johns Hopkins University Partnership To Evaluate DMT Aug 27, 2021
Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action in its Long-Acting Next… Aug 26, 2021
MINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital Therapeutics Platform to Partner Clinics… Aug 26, 2021
PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative… Aug 25, 2021
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida Aug 24, 2021
